L’Oréal USA Inc., Revlon, Inc., and other hair product companies are asking a federal court to dismiss a class action complaint alleging the companies sold relaxer products that led to an increased risk of uterine and ovarian cancer.
Thirty-four women sued L’Oréal and other companies earlier this year, alleging hair relaxer products lacked sufficient warning about the alleged cancer link, “target[ed] women of color,” and caused them economic harm. In their class action complaint, the women argued they “paid more for the Toxic Hair Relaxer Products than they would have paid had they known about the...unsafe...nature of the products.” Additionally, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
